[Federal Register Volume 65, Number 69 (Monday, April 10, 2000)]
[Notices]
[Pages 19016-19017]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-8794]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, ZDK1- GRB-7 M2.
    Date: April 11-13, 2000.
    Time: 7:30 p.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Mayflower Hotel on the Park, 15 Central Park West, 
New York, NY 10023770.
    Contact Person: Lakshmanan Sankaran, Scientific Review 
Administrator, Review Branch, DEA, NIDDK, Natcher Building Room 
6AS25F, National Institutes of Health, Bethesda, MD 20892-6600, 
(301) 594-7799.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, ZDK1 GRB-6 M1 P.
    Date: April 19-21, 2000.
    Time: 7:30 p.m. to 10 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Crowne Plaza at Dallas Market Center, 7050 Stemmons 
Freeway, Dallas, TX 75247.
    Contact Person: Neal A. Musto, Scientific Review Administrator 
Review Branch, DEA, NIDDK, Natcher Building Room 6AS-37A, National 
Institutes of Health, Bethesda, MD 20892-6600, (301) 594-7798.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel.
    Date: April 30-May 2, 2000.
    Time: 7:30 pm to 12 pm.
    Agenda: To review and evaluate grant applications.
    Place: The Majestic 1500 Sutter Street, San Francisco, CA 94109.
    Contact Person: Michele L. Barnard, Scientific Review 
Administrator, Scientific Review Administrator Review Branch, DEA, 
NIDDK, National Institutes of Health, Bethesda, MD 20892, 301/594-
8898.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, ZDK1 GRB-5(M1)P.
    Date: May 1-3, 2000.
    Time: 7:30 pm to 12 pm.
    Agenda: To review and evaluate grant applications.
    Place: Penn Tower Hotel, on the University of Penn Campus, 
Philadelphia, PA 19104-4385.
    Contact Person: Francisco O. Calvo, Deputy Chief, Review Branch, 
DEA, NIDDK, National Institutes of Health, Room 6AS37D, Bldg. 45, 
Bethesda, MD 20892, 301-594-8897.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel, ZDK1 GRB-D(M3).
    Date: May 4, 2000.
    Time: 1 pm to 2 pm.
    Agenda: To review and evaluate grant applications.
    Place: II Democracy Plaza, 6707 Democracy Boulevard, Bethesda, 
MD 20892, (Telephone Conference Call).
    Contact Person: Ann A. Hagan, Chief, National Institute of 
Diabetes, Digestive and Kidney Diseases, National Institutes of 
Health, PHS, DHHS, Rm. 6AS37, Bldg. 45, Bethesda, MD 20892, (301) 
594-8886.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: March 30, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-8794 Filed 4-7-00; 8:45 am]
BILLING CODE 4140-01-M